GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » EV-to-FCF

Cassava Sciences (MEX:SAVA) EV-to-FCF : -0.26 (As of Dec. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cassava Sciences's Enterprise Value is MXN362.69 Mil. Cassava Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-1,391.36 Mil. Therefore, Cassava Sciences's EV-to-FCF for today is -0.26.

The historical rank and industry rank for Cassava Sciences's EV-to-FCF or its related term are showing as below:

MEX:SAVA' s EV-to-FCF Range Over the Past 10 Years
Min: -88.75   Med: -4.84   Max: 4.45
Current: -0.23

During the past 13 years, the highest EV-to-FCF of Cassava Sciences was 4.45. The lowest was -88.75. And the median was -4.84.

MEX:SAVA's EV-to-FCF is ranked worse than
100% of 386 companies
in the Biotechnology industry
Industry Median: 8.605 vs MEX:SAVA: -0.23

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Cassava Sciences's stock price is MXN54.50. Cassava Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-24.808. Therefore, Cassava Sciences's PE Ratio (TTM) for today is At Loss.


Cassava Sciences EV-to-FCF Historical Data

The historical data trend for Cassava Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences EV-to-FCF Chart

Cassava Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.78 -27.33 -28.92 -12.86 -10.06

Cassava Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.89 -10.06 -8.57 -4.46 -16.19

Competitive Comparison of Cassava Sciences's EV-to-FCF

For the Biotechnology subindustry, Cassava Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cassava Sciences's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's EV-to-FCF falls into.



Cassava Sciences EV-to-FCF Calculation

Cassava Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=362.693/-1391.361
=-0.26

Cassava Sciences's current Enterprise Value is MXN362.69 Mil.
Cassava Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,391.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cassava Sciences  (MEX:SAVA) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cassava Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=54.50/-24.808
=At Loss

Cassava Sciences's share price for today is MXN54.50.
Cassava Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-24.808.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Cassava Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cassava Sciences Business Description

Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.